In these cases, resistance to bortezomib monotherapy was independent of variants in the genes encoding the β subunits, thus excluding the hypothesis that the acquired resistance to bortezomib that develops in some patients with MM is due to variants in the genes encoding the 20S CP subunits. The gene discussed is CP; the disease is Miyoshi myopathy.